315 related articles for article (PubMed ID: 16443707)
21. Lung function decline and outcomes in an elderly population.
Mannino DM; Davis KJ
Thorax; 2006 Jun; 61(6):472-7. PubMed ID: 16517577
[TBL] [Abstract][Full Text] [Related]
22. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.
Mohamed Hoesein FA; Zanen P; Lammers JW
Respir Med; 2011 Jun; 105(6):907-15. PubMed ID: 21295958
[TBL] [Abstract][Full Text] [Related]
23. Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality.
Marott JL; Ingebrigtsen TS; Çolak Y; Vestbo J; Lange P
Am J Respir Crit Care Med; 2020 Jul; 202(2):210-218. PubMed ID: 32289231
[No Abstract] [Full Text] [Related]
24. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression.
Wise RA
Am J Med; 2006 Oct; 119(10 Suppl 1):4-11. PubMed ID: 16996894
[TBL] [Abstract][Full Text] [Related]
25. It's time for an aetiology-based definition of chronic obstructive pulmonary disease.
Miravitlles M; Morera J
Respirology; 2007 May; 12(3):317-9. PubMed ID: 17539832
[No Abstract] [Full Text] [Related]
26. Attaining a correct diagnosis of COPD in general practice.
Bolton CE; Ionescu AA; Edwards PH; Faulkner TA; Edwards SM; Shale DJ
Respir Med; 2005 Apr; 99(4):493-500. PubMed ID: 15763457
[TBL] [Abstract][Full Text] [Related]
27. Relation between quality of life and morbidity and mortality in COPD patients: Two-year follow-up study.
Yorgancioglu A; Havlucu Y; Celik P; Dinc G; Saka A
COPD; 2010 Aug; 7(4):248-53. PubMed ID: 20673033
[TBL] [Abstract][Full Text] [Related]
28. Lung function decline and outcomes in an adult population.
Mannino DM; Reichert MM; Davis KJ
Am J Respir Crit Care Med; 2006 May; 173(9):985-90. PubMed ID: 16439715
[TBL] [Abstract][Full Text] [Related]
29. There is no relationship between chronic obstructive pulmonary disease and obstructive sleep apnea syndrome: a population study.
Bednarek M; Plywaczewski R; Jonczak L; Zielinski J
Respiration; 2005; 72(2):142-9. PubMed ID: 15824523
[TBL] [Abstract][Full Text] [Related]
30. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients.
Soler-Cataluña JJ; Martínez-García MA; Sánchez LS; Tordera MP; Sánchez PR
Respir Med; 2009 May; 103(5):692-9. PubMed ID: 19131231
[TBL] [Abstract][Full Text] [Related]
31. Impact of hospitalisations for exacerbations of COPD on health-related quality of life.
Esteban C; Quintana JM; Moraza J; Aburto M; Egurrola M; España PP; Pérez-Izquierdo J; Aguirre U; Aizpiri S; Capelastegui A
Respir Med; 2009 Aug; 103(8):1201-8. PubMed ID: 19272762
[TBL] [Abstract][Full Text] [Related]
32. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.
Bridevaux PO; Gerbase MW; Probst-Hensch NM; Schindler C; Gaspoz JM; Rochat T
Thorax; 2008 Sep; 63(9):768-74. PubMed ID: 18505800
[TBL] [Abstract][Full Text] [Related]
33. The 6-min walking distance: long-term follow up in patients with COPD.
Casanova C; Cote CG; Marin JM; de Torres JP; Aguirre-Jaime A; Mendez R; Dordelly L; Celli BR
Eur Respir J; 2007 Mar; 29(3):535-40. PubMed ID: 17107991
[TBL] [Abstract][Full Text] [Related]
34. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.
Johannessen A; Omenaas ER; Bakke PS; Gulsvik A
Thorax; 2005 Oct; 60(10):842-7. PubMed ID: 16085729
[TBL] [Abstract][Full Text] [Related]
35. COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study.
Miravitlles M; Izquierdo I; Herrejón A; Torres JV; Baró E; Borja J;
Respir Med; 2011 May; 105(5):740-7. PubMed ID: 21227672
[TBL] [Abstract][Full Text] [Related]
36. Predicting development and progression of COPD.
Quanjer PH; Steenbruggen I; Ruppel G; Swanney MP
Thorax; 2008 Nov; 63(11):1027-8; author reply 1028. PubMed ID: 18984822
[No Abstract] [Full Text] [Related]
37. Impact of chronic obstructive pulmonary disease exacerbations on patients and payers.
Wedzicha JA; Wilkinson T
Proc Am Thorac Soc; 2006 May; 3(3):218-21. PubMed ID: 16636088
[TBL] [Abstract][Full Text] [Related]
38. [Chronic obstructive pulmonary disease: pathophysiology, diagnosis, and therapy].
Fähndrich S; Guttmann C; Bals R
Dtsch Med Wochenschr; 2011 Sep; 136(37):1847-60; quiz 1861-2. PubMed ID: 21898277
[TBL] [Abstract][Full Text] [Related]
39. Importance of pulmonary artery to ascending aorta ratio in chronic obstructive pulmonary disease.
Iliaz S; Tanriverdio E; Chousein EGU; Ozturk S; Iliaz R; Cetinkaya E; Caglar E
Clin Respir J; 2018 Mar; 12(3):961-965. PubMed ID: 28085229
[TBL] [Abstract][Full Text] [Related]
40. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Ruiz-González A; Giménez A; Gómez-Arbonés X; Soler-González J; Sánchez V; Falguera M; Porcel JM
Respirology; 2007 Jan; 12(1):117-21. PubMed ID: 17207036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
